| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/25/2002 | US20020098521 Method and marker for the isolation of human multipotent hematopoietic stem cells |
| 07/25/2002 | US20020098469 Extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 07/25/2002 | US20020098277 Proteins are reduced with thiol redox proteins and further reacted with cystamine or oxidized glutathione to prevent reoxidation |
| 07/25/2002 | US20020098252 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098176 Inhibition of tumor growth by a nematode anticoagulant protein |
| 07/25/2002 | US20020098167 Administration of stem cells with cytokines |
| 07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 07/25/2002 | US20020098165 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
| 07/25/2002 | US20020096123 Integrated herd management system utilizing isolated populations of X-chromosome bearing and Y-chromosome bearing spermatozoa |
| 07/25/2002 | CA2435374A1 Presbyopia treatment by reducing and preventing lenticular disulfide crosslinks |
| 07/25/2002 | CA2435287A1 Nucleic acid delivery formulations |
| 07/25/2002 | CA2435248A1 Drug composition for the promotion of tissue regeneration |
| 07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | CA2434362A1 Pluripotent adult stem cells derived from regenerative tissue |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433419A1 A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/24/2002 | EP1225220A1 Dna encoding endo-beta-galactosidase |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224462A2 Isoagglutinin-depleted blood compositions and methods of making same |
| 07/24/2002 | EP1224313A1 Adeno-associated viruses and uses thereof |
| 07/24/2002 | EP1224312A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 07/24/2002 | EP1224311A1 Recombinant, replication defective celo virus and celo virus dna |
| 07/24/2002 | EP1224310A1 Recombinant adenoviruses preparation and adenovirus banks |
| 07/24/2002 | EP1224305A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224268A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 07/24/2002 | EP1224264A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 07/24/2002 | EP1224262A2 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
| 07/24/2002 | EP1224261A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 07/24/2002 | EP1224259A1 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 07/24/2002 | EP1224217A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223980A2 Use of csf-1 inhibitors |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223963A2 T-cells and molecules involved in immune regulation |
| 07/24/2002 | EP1223956A1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/24/2002 | EP1223954A1 Method and apparatus for processing blood and blood components |
| 07/24/2002 | EP1223953A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 07/24/2002 | EP1223952A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223942A2 Agents for the enhanced oxygen delivery in mammals |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | EP0820301B1 Tissue graft for urinary bladder reconstruction |
| 07/24/2002 | EP0687184B1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 07/24/2002 | EP0674497B1 Microporous macrocapsules |
| 07/24/2002 | EP0664832B1 Remyelination using neural stem cells |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360628A Method for transfer of antigens to dendritic cells |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360594A Attenuated microorganisms for treatment of infection |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360503A Compositions and uses of ET 743 for treating cancer |
| 07/24/2002 | CN1360025A Autoimmune cell for treating tumor and its preparing process |
| 07/24/2002 | CN1359714A Medicine for treating dermatopathy |
| 07/24/2002 | CN1359713A Medicine for treating syphilis |
| 07/24/2002 | CN1359700A Chinese-medicinal skin-protecting product |
| 07/24/2002 | CN1359692A Instant hypoglycemic medicine |
| 07/24/2002 | CN1359690A Chinese-medicinal ointment for treating mastopathy |
| 07/24/2002 | CN1359687A Medicine for treating cardiovascular and cerebrovascular infarction |
| 07/24/2002 | CN1359686A Zymolite of blue scad capable of improving function of brain cells and its preparing process |
| 07/24/2002 | CN1359685A Medicine for treating gastrosis and enteropathy and its preparing process |
| 07/24/2002 | CN1087952C Method for producing medicine for curing vertigo |
| 07/24/2002 | CN1087950C Dermatosis treating Chinese medicine and its preparation method |
| 07/24/2002 | CN1087949C Medicine for treating ankylosing spondylitis and method for preparing same |
| 07/24/2002 | CN1087941C Compositions for prevention and treatment of viral-induced tumors |
| 07/24/2002 | CN1087940C Brain protein hydrolysate |
| 07/23/2002 | US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/23/2002 | US6423681 Method of inducing formation of kidney epithelia from mesenchymal precursors |
| 07/23/2002 | US6423540 Cell differentiation protein |
| 07/23/2002 | US6423496 Nucleotide sequences for use in the detection, diagnosis and monitoring of mammary gland tumors |
| 07/23/2002 | US6423347 Antiarthritic agents in liquid form |
| 07/23/2002 | US6423320 Inhibitor of immunoglobulin E antibody production |
| 07/23/2002 | US6423318 Hepatitis A virus vaccines |
| 07/23/2002 | US6423311 Mammals grafting cells with radiation |
| 07/23/2002 | CA2270195C Pharmaceutical composition for treatment of diabetes |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2051092C Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055678A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues |
| 07/18/2002 | WO2002055677A1 Transplantation cell kits for re-myelination in nerve cells |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055095A2 Use of aziridino-compounds in the treatment of immune dysfunctions |
| 07/18/2002 | WO2002055049A1 Cosmetic and/or pharmaceutical preparations |
| 07/18/2002 | WO2002055048A1 Cosmetic and/or pharmaceutical preparations |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002054873A2 Microbiological agents for the control of sea lice |
| 07/18/2002 | WO2002054851A2 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |